[Photoshop] Halo
- Thread starter Flaw
- Start date
NarutoGoku
Active member
Awards
甲型h1n1流感与季节性流感不同
世界卫生组织指出，季节性流行感冒病毒已经对药品达菲（Tamiflu）产生抵抗能力，为此，该组织已经加紧进行甲型H1N1流感疫苗的培育工作。 世界卫生组织全球流感项目专家进藤奈邦子（Nikki Shindo）昨天在日内瓦的每日记者会上说，墨西哥和美国的甲型H1N1流感病人的住院率比较高，这使得疫苗的培育工作必须加紧进行，因为，我们面对的可能是有抗药能力的病毒。 进藤奈邦子说：“去年的季节性流感爆发时，病毒产生了抵抗药物奥斯他韦（oseltamivir，达菲的主要成份）的能力。” 达菲是瑞士罗氏（Roche Holding AG）制药公司的产品，该公司已经决定捐出565万剂的达菲，供世界卫生组织应付甲型H1N1流感；公司也会在未来五个月增加达菲的产量。目前，在疫苗尚未培育成功的情况下，只有达菲和英国葛兰素史克公司生产的瑞乐砂（Relenza）能抗流感。 进藤指出，虽然甲型H1N1流感的传染力比季节性流感强、症状也比较严重，但多数患者可以通过休息和补充水分康复，所以没有必要用达菲和瑞乐沙。她认为，慎重的做法是将这些药物省下来，用于治疗怀孕妇女、心血管疾病或糖尿病等疾病患者，因为这些人一旦感染甲型H1N1流感病毒，会出现严重的病情。 从美国与墨西哥的数据来看，感染病毒以致情况严重至需要入院的人占9％至10％。进藤说：“这与季节性流感不同。” 美国的3009个甲型H1N1流感病人当中，116个需要住院。美国疾病控制与预防中心的科学与公共卫生署代署长舒查特说，孕妇看来特别会因为感染甲型H1N1流感而发病；因此，同季节性流感一样，孕妇需要立刻接受治疗。她认为，美国的病例只是冰山的一角，因为，好些病人没有服药便痊愈，没有取病毒样本供实验室化验，没有列为病例。 最先传出病例的墨西哥有58个病人死亡，全球的5251个病例当中，近九成来自墨西哥和美国。但进藤指出，用药用得最多的却是多数只有“入口”病例的欧洲国家。
世界卫生组织指出，季节性流行感冒病毒已经对药品达菲（Tamiflu）产生抵抗能力，为此，该组织已经加紧进行甲型H1N1流感疫苗的培育工作。 世界卫生组织全球流感项目专家进藤奈邦子（Nikki Shindo）昨天在日内瓦的每日记者会上说，墨西哥和美国的甲型H1N1流感病人的住院率比较高，这使得疫苗的培育工作必须加紧进行，因为，我们面对的可能是有抗药能力的病毒。 进藤奈邦子说：“去年的季节性流感爆发时，病毒产生了抵抗药物奥斯他韦（oseltamivir，达菲的主要成份）的能力。” 达菲是瑞士罗氏（Roche Holding AG）制药公司的产品，该公司已经决定捐出565万剂的达菲，供世界卫生组织应付甲型H1N1流感；公司也会在未来五个月增加达菲的产量。目前，在疫苗尚未培育成功的情况下，只有达菲和英国葛兰素史克公司生产的瑞乐砂（Relenza）能抗流感。 进藤指出，虽然甲型H1N1流感的传染力比季节性流感强、症状也比较严重，但多数患者可以通过休息和补充水分康复，所以没有必要用达菲和瑞乐沙。她认为，慎重的做法是将这些药物省下来，用于治疗怀孕妇女、心血管疾病或糖尿病等疾病患者，因为这些人一旦感染甲型H1N1流感病毒，会出现严重的病情。 从美国与墨西哥的数据来看，感染病毒以致情况严重至需要入院的人占9％至10％。进藤说：“这与季节性流感不同。” 美国的3009个甲型H1N1流感病人当中，116个需要住院。美国疾病控制与预防中心的科学与公共卫生署代署长舒查特说，孕妇看来特别会因为感染甲型H1N1流感而发病；因此，同季节性流感一样，孕妇需要立刻接受治疗。她认为，美国的病例只是冰山的一角，因为，好些病人没有服药便痊愈，没有取病毒样本供实验室化验，没有列为病例。 最先传出病例的墨西哥有58个病人死亡，全球的5251个病例当中，近九成来自墨西哥和美国。但进藤指出，用药用得最多的却是多数只有“入口”病例的欧洲国家。
Re: 甲型h1n1流感与季节性流感不同
World Health Organization, pointed out that the seasonal influenza virus has the drug Tamiflu (Tamiflu) produce resistance to this end, the organization has stepped up the cultivation of influenza A H1N1 influenza vaccine work. World Health Organization Global Influenza Program Specialist Shinto Naibang child (Nik ki Shindo) yesterday in the daily press conference in Geneva, Mexico and the United States, influenza A H1N1 influenza hospitalization rate is relatively high, which makes vaccine development work must be stepped up carried out, because we might be faced with resistance to the virus. Shinto Naibang son, said: "Last year's seasonal influenza outbreaks, the virus had a resistance to drug oseltamivir (oseltamivir, Tamiflu is the main ingredient) capabilities." Tamiflu is Switzerland's Roche (Roche Holding AG) Pharmaceuticals The company's products, the company has decided to donate 5.65 million of Tamiflu for the World Health Organization to cope with Influenza A H1N1 influenza; the company will be in the next five months to increase production of Tamiflu. At present, the successful cultivation of the vaccine has not yet the case, only Tamiflu and the British company GlaxoSmithKline's Relenza (Relenza) can be anti-flu. Shinto noted that although the influenza A H1N1 influenza contagious stronger than the seasonal flu, the symptoms are more serious, but most patients can rest and hydration through rehabilitation, there is no need to use Tamiflu and Relenza. In her view, prudent practice is to these drugs could be saved, for the treatment of pregnant women, cardiovascular disease or diabetes and other diseases, because once these people are infected with influenza A H1N1 influenza virus, there will be a serious condition. From the United States and Mexico data, so the virus to be hospitalized in serious condition who accounted for 9-10%. Shinto, said: "This is different from seasonal influenza." United States, 3009 Influenza A H1N1 influenza patients, 116 required hospitalization. U.S. Centers for Disease Control and Prevention, Center for Science and Public Health Department on behalf of the Director of Shu Chatterton said that pregnant women appear to be particularly because of the incidence of influenza infection of influenza A H1N1; so, as with seasonal influenza, pregnant women in need of immediate treatment. She believes that the U.S. case is just the tip of the iceberg, because there is no better medication the patient will be cured, there is no virus samples taken for laboratory testing, not classified as cases. The first came in Mexico there are 58 cases of patients died, the global 5251 cases Nearly nine from Mexico and the United States. But Shinto pointed out that the drugs most used are the majority only "entry" cases in European countries.
It's Chinese. Google translate:
World Health Organization, pointed out that the seasonal influenza virus has the drug Tamiflu (Tamiflu) produce resistance to this end, the organization has stepped up the cultivation of influenza A H1N1 influenza vaccine work. World Health Organization Global Influenza Program Specialist Shinto Naibang child (Nik ki Shindo) yesterday in the daily press conference in Geneva, Mexico and the United States, influenza A H1N1 influenza hospitalization rate is relatively high, which makes vaccine development work must be stepped up carried out, because we might be faced with resistance to the virus. Shinto Naibang son, said: "Last year's seasonal influenza outbreaks, the virus had a resistance to drug oseltamivir (oseltamivir, Tamiflu is the main ingredient) capabilities." Tamiflu is Switzerland's Roche (Roche Holding AG) Pharmaceuticals The company's products, the company has decided to donate 5.65 million of Tamiflu for the World Health Organization to cope with Influenza A H1N1 influenza; the company will be in the next five months to increase production of Tamiflu. At present, the successful cultivation of the vaccine has not yet the case, only Tamiflu and the British company GlaxoSmithKline's Relenza (Relenza) can be anti-flu. Shinto noted that although the influenza A H1N1 influenza contagious stronger than the seasonal flu, the symptoms are more serious, but most patients can rest and hydration through rehabilitation, there is no need to use Tamiflu and Relenza. In her view, prudent practice is to these drugs could be saved, for the treatment of pregnant women, cardiovascular disease or diabetes and other diseases, because once these people are infected with influenza A H1N1 influenza virus, there will be a serious condition. From the United States and Mexico data, so the virus to be hospitalized in serious condition who accounted for 9-10%. Shinto, said: "This is different from seasonal influenza." United States, 3009 Influenza A H1N1 influenza patients, 116 required hospitalization. U.S. Centers for Disease Control and Prevention, Center for Science and Public Health Department on behalf of the Director of Shu Chatterton said that pregnant women appear to be particularly because of the incidence of influenza infection of influenza A H1N1; so, as with seasonal influenza, pregnant women in need of immediate treatment. She believes that the U.S. case is just the tip of the iceberg, because there is no better medication the patient will be cured, there is no virus samples taken for laboratory testing, not classified as cases. The first came in Mexico there are 58 cases of patients died, the global 5251 cases Nearly nine from Mexico and the United States. But Shinto pointed out that the drugs most used are the majority only "entry" cases in European countries.
MentalJerk
Active member
Awards
WOW!!! =O
The whole forum is on a huge progress GFXly =O
Even this object [YES YOU!] did a nice sig =O
The text SUCKS!! just that =]
The whole forum is on a huge progress GFXly =O
Even this object [YES YOU!] did a nice sig =O
The text SUCKS!! just that =]
